In an announcement of the study on the Vanderbilt website, lead author Khrysta Baig described this as a purely hypothetical scenario, but one that underscores that at current prices, these medications cannot be the only way or even the main way we address obesity as a society. In a more conservative estimate, Bhaig and coauthors consider a case where only about 10% of those eligible for obesity treatment opted for semaglutide, which would result in $27 billion in new costs
Research shows that: You may find that the side effects of semaglutide appear at different times of the day, such as when youve eaten or after taking your weekly dose
It appears to offer several benefits, including blood sugar control, weight loss, and may even reduce cravings and emotional eating
Because dulaglutide already has proven cardiovascular benefit, demonstrating non-inferiority against it is notable
Get expert, physician-supervised weight loss in Anthem, Surprise, Phoenix, Peoria, Glendale, Scottsdale and surrounding areas